Scintigraphic Load of Bone Disease Evaluated by DASciS Software as a Survival Predictor in Metastatic Castration-resistant Prostate Cancer Patients Candidates to 223RaCl Treatment

BACKGROUND: Aim of our study was to assess the load of bone disease at starting and during Ra-223 treatment as an overall survival (OS) predictor in metastatic castration-resistant prostate cancer (mCRPC) patients. Bone scan index (BSI) is defined as the percentage of total amount of bone metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantellizzi, Viviana, Pani, Arianna, Ippoliti, Maria Dea, Farcomeni, Alessio, Aloise, Irvin, Colosi, Mirco, Polito, Claudia, Pani, Roberto, Vincentis, Giuseppe De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087429/
https://www.ncbi.nlm.nih.gov/pubmed/31855572
http://dx.doi.org/10.2478/raon-2019-0058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087429/
https://www.ncbi.nlm.nih.gov/pubmed/31855572
http://dx.doi.org/10.2478/raon-2019-0058

Ejemplares similares